Linked Data API

Show Search Form

Search Results

513011
registered interest false more like this
date less than 2016-04-14more like thismore than 2016-04-14
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading HIV Infection: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what the evidential basis is for NHS England's decision not to fund the pre-exposure drug prophyaxis for HIV for the at-risk population. more like this
tabling member constituency Erewash more like this
tabling member printed
Maggie Throup remove filter
uin 34125 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2016-04-21more like thismore than 2016-04-21
answer text <p>NHS England has placed its position on the commissioning of pre-exposure prophylaxis (PrEP) under review. This review of the commissioning process will be undertaken by the Specialised Services Committee of NHS England in late May 2016. Depending on the outcome of that decision, a further decision taking account of the clinical evidence for PrEP, the evidence and demand for other new treatments not currently commissioned and NHS England's available funding and priorities is currently planned for June 2016.</p> more like this
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2016-04-21T14:19:15.423Zmore like thismore than 2016-04-21T14:19:15.423Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
4447
label Biography information for Maggie Throup more like this
513019
registered interest false more like this
date less than 2016-04-14more like thismore than 2016-04-14
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading HIV Infection: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, which areas have been chosen as test sites for the pre-exposure drug prophyaxis (PrEP); what selection criteria have been used to identify those test sites; and what measures his Department plans to use to assess the effectiveness of PrEP in the test sites over the next two years. more like this
tabling member constituency Erewash more like this
tabling member printed
Maggie Throup remove filter
uin 34127 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2016-04-22more like thismore than 2016-04-22
answer text <p>The planning of the process to select test sites, including timing and criteria for selection, will continue alongside NHS England’s review of its position on the commissioning of pre-exposure prophyaxis (PrEP).</p> more like this
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2016-04-22T13:06:13.567Zmore like thismore than 2016-04-22T13:06:13.567Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
4447
label Biography information for Maggie Throup more like this